Matthew Collin

34PUBLICATIONS
299CO-AUTHORS
HaematologyMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 23, 2026
A European study on blood mutation monitoring in children with BRAFV600E-positive Langerhans Cell Histiocytosis.

|Oct 07, 2026
MEK inhibition achieves robust and durable responses in Erdheim-Chester disease.

|Aug 06, 2026
A quantitative definition of the clinical manifestations of GATA2 deficiency in adults.

|Jun 17, 2026
Outcome of treatment with trametinib in adults with histiocytic neoplasms in the United Kingdom.

|Feb 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Jean Donadieu, Dmitry Evseev, Francesco Pegoraro

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

Pageof 6

Frequent Collaborators

7 joint publications

Venetia Bigley

7 joint publications

Paul Milne

4 joint publications

Clare Lendrem

4 joint publications

Jean-François Emile